Rivastigmine
NDC 65162-825, Rivastigmine, patch, from Amneal Pharmaceuticals LLC.
- Product NDC
- 65162-825
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals LLC
- Dosage form
- PATCH
- Route
- TRANSDERMAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207308
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65162-825 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RIVASTIGMINE4.6 mg/24h
Pharmacologic classes
Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65162-825-34 | 65162082534 | 30 PATCH in 1 CARTON (65162-825-34) / 24 h in 1 PATCH |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/8b671fc9-8cb0-4406-a9ee-7c95086d6200NADAC price for package 65162082534
GET /v1/drugs/nadac/65162082534
Use it
Look up 65162-825 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65162-825 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65162-825. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.